Macquarie Group’s ADMA Biologics ADMA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $28.7M | Buy |
1,574,541
+128,151
| +9% | +$2.33M | 0.04% | 563 |
|
|
2025
Q1 | $28.7M | Buy |
1,446,390
+431,701
| +43% | +$8.56M | 0.04% | 556 |
|
|
2024
Q4 | $17.4M | Sell |
1,014,689
-123,634
| -11% | -$2.12M | 0.02% | 680 |
|
|
2024
Q3 | $22.8M | Buy |
1,138,323
+955,990
| +524% | +$19.1M | 0.02% | 636 |
|
|
2024
Q2 | $2.04M | Sell |
182,333
-66,281
| -27% | -$741K | ﹤0.01% | 1217 |
|
|
2024
Q1 | $1.64M | Sell |
248,614
-25,622
| -9% | -$169K | ﹤0.01% | 1279 |
|
|
2023
Q4 | $1.24M | Buy |
+274,236
| New | +$1.24M | ﹤0.01% | 1334 |
|